Shufro Rose & Co’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.66M | Sell |
2,623
-16
| -0.6% | -$10.1K | 0.13% | 85 |
|
|
2025
Q1 | $1.67M | Sell |
2,639
-47
| -2% | -$29.8K | 0.13% | 87 |
|
|
2024
Q4 | $1.91M | Buy |
2,686
+2,393
| +817% | +$1.7M | 0.15% | 79 |
|
|
2024
Q3 | $308K | Hold |
293
| – | – | 0.03% | 231 |
|
|
2024
Q2 | $308K | Hold |
293
| – | – | 0.03% | 231 |
|
|
2024
Q1 | $282K | Hold |
293
| – | – | 0.02% | 239 |
|
|
2023
Q4 | $241K | Hold |
293
| – | – | 0.02% | 242 |
|
|
2023
Q3 | $241K | Sell |
293
-50
| -15% | -$41.1K | 0.02% | 242 |
|
|
2023
Q2 | $246K | Sell |
343
-100
| -23% | -$71.9K | 0.02% | 245 |
|
|
2023
Q1 | $364K | Hold |
443
| – | – | 0.03% | 203 |
|
|
2022
Q4 | $320K | Hold |
443
| – | – | 0.03% | 224 |
|
|
2022
Q3 | $305K | Hold |
443
| – | – | 0.03% | 222 |
|
|
2022
Q2 | $262K | Sell |
443
-15
| -3% | -$8.87K | 0.02% | 239 |
|
|
2022
Q1 | $320K | Sell |
458
-388
| -46% | -$271K | 0.02% | 225 |
|
|
2021
Q4 | $534K | Buy |
846
+12
| +1% | +$7.57K | 0.04% | 178 |
|
|
2021
Q3 | $505K | Hold |
834
| – | – | 0.04% | 172 |
|
|
2021
Q2 | $466K | Buy |
834
+4
| +0.5% | +$2.24K | 0.04% | 167 |
|
|
2021
Q1 | $393K | Hold |
830
| – | – | 0.03% | 187 |
|
|
2020
Q4 | $401K | Buy |
830
+230
| +38% | +$111K | 0.03% | 176 |
|
|
2020
Q3 | $336K | Hold |
600
| – | – | 0.03% | 196 |
|
|
2020
Q2 | $374K | Hold |
600
| – | – | 0.04% | 183 |
|
|
2020
Q1 | $293K | Hold |
600
| – | – | 0.03% | 198 |
|
|
2019
Q4 | $225K | Buy |
+600
| New | +$225K | 0.02% | 257 |
|
|
2019
Q2 | – | Sell |
-600
| Closed | -$246K | – | 307 |
|
|
2019
Q1 | $246K | Hold |
600
| – | – | 0.02% | 239 |
|
|
2018
Q4 | $224K | Hold |
600
| – | – | 0.02% | 236 |
|
|
2018
Q3 | $242K | Hold |
600
| – | – | 0.02% | 253 |
|
|
2018
Q2 | $207K | Sell |
600
-100
| -14% | -$34.5K | 0.02% | 258 |
|
|
2018
Q1 | $241K | Hold |
700
| – | – | 0.02% | 250 |
|
|
2017
Q4 | $263K | Buy |
700
+100
| +17% | +$37.6K | 0.03% | 237 |
|
|
2017
Q3 | $268K | Buy |
+600
| New | +$268K | 0.03% | 240 |
|
|
2016
Q3 | – | Sell |
-600
| Closed | -$210K | – | 273 |
|
|
2016
Q2 | $210K | Sell |
600
-2,737
| -82% | -$958K | 0.02% | 234 |
|
|
2016
Q1 | $1.2M | Buy |
+3,337
| New | +$1.2M | 0.13% | 104 |
|